Improving outcomes after relapse in Ewing's sarcoma: Analysis of 114 patients from a single institution

Sarcoma

Volumn 2006, Issue , 2006, Pages

  McTiernan, Anne M ^a   Cassoni, Anna M ^a   Driver, Deirdre ^a   Michelagnoli, Maria P ^a   Kilby, Anne M ^a   Whelan, Jeremy S ^a  

^a UNIVERSITY COLLEGE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; BUSULFAN; CARBOPLATIN; CISPLATIN; CYCLOPHOSPHAMIDE; DACTINOMYCIN; DOXORUBICIN; ETOPOSIDE; IFOSFAMIDE; MELPHALAN; TOPOTECAN; VINCRISTINE;

ADOLESCENT; ADULT; AMPUTATION; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURGERY; CANCER SURVIVAL; CHILD; CLINICAL TRIAL; DRUG MEGADOSE; EWING SARCOMA; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; METASTASIS; MULTIMODALITY CANCER THERAPY; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; PROGNOSIS; RELAPSE; TREATMENT OUTCOME;

EID: 34547648038     PISSN: 1357714X     EISSN: 13691643     Source Type: Journal    
DOI: 10.1155/SRCM/2006/83548     Document Type: Article

References (25)

1. C Rodriguez-Galindo C A Billups L E Kun Survival after recurrence of Ewing tumors: the St. Jude children's research hospital experience, 1979-1999. Cancer 94 2 2002 561 569
2. A G Shankar a.shankar@cancer.org.uk S Ashley A W Craft C R Pinkerton Outcome after relapse in an unselected cohort of children and adolescents with Ewing sarcoma. Medical and Pediatric Oncology 40 3 2003 141 147
3. G Bacci gaetano.bacci@ior.it S Ferrari A Longhi Therapy and survival after recurrence of Ewing's tumors: the Rizzoli experience in 195 patients treated with adjuvant and neoadjuvant chemotherapy from 1979 to 1997. Annals of Oncology 14 11 2003 1654 1659
4. A Craft a.w.craft@ncl.ac.uk S Cotterill A Malcolm Ifosfamide-containing chemotherapy in Ewing's sarcoma: the second United Kingdom Children's Cancer Study Group and the Medical Research Council Ewing's Tumor Study. Journal of Clinical Oncology 16 11 1998 3628 3633
5. M Paulussen A Craft I Lewis Ewing tumor of bone - updated report of the European Intergroup Cooperative Ewing's Sarcoma Study EICESS 92. Proceedings of the American Society of Clinical Oncology 21 abstract 2002 1568
6. S J Strauss A McTiernan D Driver Single center experience of a new intensive induction therapy for Ewing's family of tumors: feasibility, toxicity, and stem cell mobilization properties. Journal of Clinical Oncology 21 15 2003 2974 2981
7. E L Kaplan P Meier Nonparametric estimation from incomplete observations. Journal of the American Statistical Association 53 1958 282 457 481
8. D R Cox D Oakes Analysis of Survival Data. Chapman and Hall London, UK 1984
9. J S Whelan jeremy.whelan@uclh.org A McTiernan E Kakouri A Kilby Carboplatin-based chemotherapy for refractory and recurrent Ewing's tumours. Pediatric Blood and Cancer 43 3 2004 237 242
10. B M Seddon A McTiernan M Michelagnoli S Gabbie S Daw J S Whelan High-dose ifosfamide in relapsed or progressive Ewing's sarcoma. Sarcoma 9 abstract 2005 108
11. G Bacci chemioterapia@ior.it S Ferrari F Bertoni Prognostic factors in nonmetastatic Ewing's sarcoma of bone treated with adjuvant chemotherapy: analysis of 359 patients at the Istituto Ortopedico Rizzoli. Journal of Clinical Oncology 18 1 2000 4 11
12. A W Craft S J Cotterill J A Bullimore D Pearson Long-term results from the first UKCCSG Ewing's tumour study (ET-1). United Kingdom Children's Cancer Study Group (UKCCSG) and the Medical Research Council Bone Sarcoma Working Party. European Journal of Cancer 33 7 1997 1061 1069
13. M Paulussen S Ahrens J Dunst Localized Ewing tumor of bone: final results of the Cooperative Ewing's Sarcoma Study CESS 86. Journal of Clinical Oncology 19 6 2001 1818 1829
14. L H Wexler T F DeLaney M Tsokos Ifosfamide and etoposide plus vincristine, doxorubicin, and cyclophosphamide for newly diagnosed Ewing's sarcoma family of tumors. Cancer 78 4 1996 901 911
15. A G Shankar C R Pinkerton rossp@icr.ac.uk A Atra Local therapy and other factors influencing site of relapse in patients with localised Ewing's sarcoma. United Kingdom Children's Cancer Study Group (UKCCSG). European Journal of Cancer 35 12 1999 1698 1704
16. G Bacci gaetano.bacci@ior.it S Ferrari M Mercuri Multimodal therapy for the treatment of nonmetastatic Ewing sarcoma of pelvis. Journal of Pediatric Hematology/Oncology 25 2 2003 118 124
17. F A Hayes E I Thompson M Kumar H O Hustu Long-term survival in patients with Ewing's sarcoma relapsing after completing therapy. Medical and Pediatric Oncology 15 5 1987 254 256
18. M Paulussen S Ahrens G Braun-Munzinger Survival in primary disseminated or relapsed Ewing's tumor-EICESS/CESS data. Medical and Pediatric Oncology 27 abstract 1996 237
19. L M Barker T W Pendergrass J E Sanders D S Hawkins Survival after recurrence of Ewing's sarcoma family of tumors. Journal of Clinical Oncology 23 19 2005 4354 4362
20. G Bacci P Picci S Ferrari Neoadjuvant chemotherapy for Ewing's sarcoma of bone: no benefit observed after adding ifosfamide and etoposide to vincristine, actinomycin, cyclophosphamide, and doxorubicin in the maintenance phase - results of two sequential studies. Cancer 82 6 1998 1174 1183
21. G Bacci M Mercuri A Longhi Neoadjuvant chemotherapy for Ewing's tumour of bone: recent experience at the Rizzoli Orthopaedic Institute. European Journal of Cancer 38 17 2002 2243 2251
22. S J Cotterill S Ahrens M Paulussen Prognostic factors in Ewing's tumor of bone: analysis of 975 patients from the European Intergroup Cooperative Ewing's Sarcoma Study Group. Journal of Clinical Oncology 18 17 2000 3108 3114
23. R Ladenstein C Lasset R Pinkerton Impact of megatherapy in children with high-risk Ewing's tumours in complete remission: a report from the EBMT Solid Tumour Registry. Bone Marrow Transplantation 15 5 1995 697 705
24. B Frohlich S Ahrens S Burdach High-dosage chemotherapy in primary metastasized and relapsed Ewing's sarcoma. (EI)CESS. Klinische Pädiatrie 211 1999 4 284 290
25. J S Whelan R J Burcombe J Janinis A M Baldelli A M Cassoni A systematic review of the role of pulmonary irradiation in the management of primary bone tumours. Annals of Oncology 13 1 2002 23 30